[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @bmsnews Bristol Myers Squibb Bristol Myers Squibb posts on X about acquisition, future of the most. They currently have XXXXXXX followers and X posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::34010976/interactions)  - X Week XXXXX +3.30% - X Month XXXXX +168% - X Months XXXXXX +33% - X Year XXXXXX -XX% ### Mentions: X [#](/creator/twitter::34010976/posts_active)  - X Week X no change - X Month X -XX% - X Months XX +41% - X Year XX +167% ### Followers: XXXXXXX [#](/creator/twitter::34010976/followers)  - X Week XXXXXXX +0% - X Month XXXXXXX -XXXX% - X Months XXXXXXX -XXXX% - X Year XXXXXXX -XXXX% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::34010976/influencer_rank)  ### Social Influence [#](/creator/twitter::34010976/influence) --- **Social category influence** [stocks](/list/stocks) XX% [finance](/list/finance) XX% **Social topic influence** [acquisition](/topic/acquisition) 20%, [future of](/topic/future-of) XX% **Top accounts mentioned or mentioned by** [@annasylwes94870](/creator/undefined) [@j0nnysalami](/creator/undefined) [@mikekinney16](/creator/undefined) [@phrma](/creator/undefined) [@spiking](/creator/undefined) [@etpharma](/creator/undefined) [@maawlaw](/creator/undefined) [@kir97657399](/creator/undefined) [@dollpolitics](/creator/undefined) [@heather40611171](/creator/undefined) [@evotec](/creator/undefined) [@capnbrunchusa](/creator/undefined) [@usfda](/creator/undefined) [@cathyengmd](/creator/undefined) [@danbudwick](/creator/undefined) [@inside_pm](/creator/undefined) [@olivervarhelyi](/creator/undefined) [@medadnews](/creator/undefined) [@ufotl](/creator/undefined) [@jeffreylowmd](/creator/undefined) ### Top Social Posts [#](/creator/twitter::34010976/posts) --- Top posts by engagements in the last XX hours "Today we announced an agreement to acquire Orbital Therapeutics. This acquisition strengthens our industry-leading cell therapy portfolio and brings us closer to delivering next-generation CAR T-cell therapies to more patients. Learn more:" [X Link](https://x.com/bmsnews/status/1976656849207193816) [@bmsnews](/creator/x/bmsnews) 2025-10-10T14:31Z 152.8K followers, 1575 engagements "#MEDIA: Announcing upcoming data presentations at #ESMO25 from our oncology portfolio and pipeline. These data span many novel mechanisms and modalities with the goal of improving patient outcomes across tumor types" [X Link](https://x.com/bmsnews/status/1977690974202515755) [@bmsnews](/creator/x/bmsnews) 2025-10-13T11:00Z 152.8K followers, 1295 engagements "#MEDIA: Announcing first disclosure of results at #ESMO25 from the global Phase X BL-B01D1-LUNG XXX trial evaluating a bispecific antibody-drug conjugate in certain NSCLC patients and other solid tumors" [X Link](https://x.com/bmsnews/status/1979191961136357824) [@bmsnews](/creator/x/bmsnews) 2025-10-17T14:25Z 152.8K followers, 1136 engagements "Healthcare professionals have the power to impact patient lives every day. Not for recognition but because it's their calling. Meet the Champions in Care helping to shape the future of health: #OneBMS" [X Link](https://x.com/bmsnews/status/1980257694104571943) [@bmsnews](/creator/x/bmsnews) 2025-10-20T13:00Z 152.8K followers, 1329 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Bristol Myers Squibb posts on X about acquisition, future of the most. They currently have XXXXXXX followers and X posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks XX% finance XX%
Social topic influence acquisition 20%, future of XX%
Top accounts mentioned or mentioned by @annasylwes94870 @j0nnysalami @mikekinney16 @phrma @spiking @etpharma @maawlaw @kir97657399 @dollpolitics @heather40611171 @evotec @capnbrunchusa @usfda @cathyengmd @danbudwick @inside_pm @olivervarhelyi @medadnews @ufotl @jeffreylowmd
Top posts by engagements in the last XX hours
"Today we announced an agreement to acquire Orbital Therapeutics. This acquisition strengthens our industry-leading cell therapy portfolio and brings us closer to delivering next-generation CAR T-cell therapies to more patients. Learn more:"
X Link @bmsnews 2025-10-10T14:31Z 152.8K followers, 1575 engagements
"#MEDIA: Announcing upcoming data presentations at #ESMO25 from our oncology portfolio and pipeline. These data span many novel mechanisms and modalities with the goal of improving patient outcomes across tumor types"
X Link @bmsnews 2025-10-13T11:00Z 152.8K followers, 1295 engagements
"#MEDIA: Announcing first disclosure of results at #ESMO25 from the global Phase X BL-B01D1-LUNG XXX trial evaluating a bispecific antibody-drug conjugate in certain NSCLC patients and other solid tumors"
X Link @bmsnews 2025-10-17T14:25Z 152.8K followers, 1136 engagements
"Healthcare professionals have the power to impact patient lives every day. Not for recognition but because it's their calling. Meet the Champions in Care helping to shape the future of health: #OneBMS"
X Link @bmsnews 2025-10-20T13:00Z 152.8K followers, 1329 engagements
/creator/x::bmsnews